SARS-CoV-2 Omicron variant shedding during respiratory activities.
Int J Infect Dis 2023;
131:19-25. [PMID:
36948451 PMCID:
PMC10028358 DOI:
10.1016/j.ijid.2023.03.029]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2022] [Revised: 02/24/2023] [Accepted: 03/13/2023] [Indexed: 03/24/2023] Open
Abstract
BACKGROUND
As the world transitions to COVID-19 endemicity, studies focusing on aerosol shedding of highly transmissible SARS-CoV-2 variants of concern (VOCs) are vital for the calibration of infection control measures against VOCs that are likely to circulate seasonally.
OBJECTIVE
This follow-up G-II aerosol sampling study aims to compare the aerosol shedding patterns of Omicron VOC samples with pre-Omicron variants analyzed in our previous study.
STUDY DESIGN
Coarse and fine aerosol samples from 47 SARS-CoV-2 infected patients were collected during various respiratory activities (passive breathing, talking, and singing) and analyzed via reverse transcription quantitative polymerase chain reaction (RT-qPCR) and virus culture.
RESULTS
Compared to patients infected with pre-Omicron variants, comparable SARS-CoV-2 RNA copy numbers were detectable in aerosol samples of Omicron infected patients despite being fully vaccinated. Omicron-infected patients also showed a slight increase in viral aerosol shedding during breathing activities, and were more likely to have persistent aerosol shedding beyond 7 days post-disease onset.
CONCLUSION
This follow-up study reaffirms the aerosol shedding properties of Omicron, and should guide continued layering of public health interventions even in highly vaccinated populations.
Collapse